Cabometyx 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FCFJ9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,822
Award facts
- Contract value 100% obligated
- $16,822.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16.8K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 30 tablets of Cabometyx 40 mg on November 6, 2025, with an ultimate completion date of November 7, 2025. This delivery order carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award was funded by the Defense Logistics Agency and will be performed at the awardee's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. That underlying IDC, valued at $500M with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. Cabometyx, an oncology treatment, aligns with DMS Pharmaceutical Group's established product portfolio of specialized pharmaceuticals that support the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCFJ9?
SPE2DR26FCFJ9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FCFJ9 worth?
The government has obligated $16,822 on SPE2DR26FCFJ9.
Is contract SPE2DR26FCFJ9 an order under another contract?
Yes. SPE2DR26FCFJ9 is a delivery order under SPE2DR25D9133, an indefinite delivery contract.
Was contract SPE2DR26FCFJ9 competed?
The extent of competition for SPE2DR26FCFJ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award